Abstract
Bifidobacteria are members of the human gut microbiota, which are known to influence the metabolic abilities of their host. Here, we investigated the capabilities of bifidobacteria to reduce cholesterol levels in synthetic growth media, clearly demonstrating assimilation of this molecule by particular bifidobacterial strains, including Bifidobacterium bifidum PRL2010 (LMG S-28692). The transcriptomic analysis of PRL2010 cells cultivated in the presence of cholesterol revealed a significantly increased transcription level of genes encoding putative transporters and reductases, indicative of specific mechanisms for cholesterol assimilation as well as cholesterol conversion to coprostanol. Cholesterol lowering activity of B. bifidum PRL2010 cells was further evaluated by means of an in vivo murine model, showing that the fecal microbiota of mice is modified toward those bacteria involved in the metabolism of cholesterol.
Similar content being viewed by others
References
Begley M, Hill C, Gahan CG (2006) Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 72(3):1729–1738. doi:10.1128/AEM. 72.3.1729-1738.2006
Bilban M, Buehler LK, Head S, Desoye G, Quaranta V (2002) Defining signal thresholds in DNA microarrays: exemplary application for invasive cancer. BMC Genomics 3(1):19
Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19(2):185–193
Bordoni A, Amaretti A, Leonardi A, Boschetti E, Danesi F, Matteuzzi D, Roncaglia L, Raimondi S, Rossi M (2013) Cholesterol-lowering probiotics: in vitro selection and in vivo testing of bifidobacteria. Appl Microbiol Biotechnol 97(18):8273–8281. doi:10.1007/s00253-013-5088-2
Bottacini F, O’ Connell Motherway M, Kuczynski J, O' Connell KJ, Serafini F, Duranti S, Milani C, Turroni F, Lugli GA, Zomer A, Zhurina D, Riedel C, Ventura M, van Sinderen D (2014) Comparative genomics of the Bifidobacterium breve taxon. BMC Genomics 1(15):170
Brzostek A, Pawelczyk J, Rumijowska-Galewicz A, Dziadek B, Dziadek J (2009) Mycobacterium tuberculosis is able to accumulate and utilize cholesterol. J Bacteriol 191(21):6584–6591. doi:10.1128/JB.00488-09
Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7(5):335–336. doi:10.1038/nmeth.f.303
Charbonneau A, The VL (2001) Genomic organization of a human 5beta-reductase and its pseudogene and substrate selectivity of the expressed enzyme. Biochim Biophys Acta 1517(2):228–235
Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, Kulam-Syed-Mohideen AS, McGarrell DM, Marsh T, Garrity GM, Tiedje JM (2009) The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37(Database issue):D141–D145. doi:10.1093/nar/gkn879
Dowhan W, Bogdanov M, Mileykovskaya E (2008) Functional roles of lipids in membranes, 5th edn. Elsevier Science, Amsterdam, p 1–37
Drzyzga O, Fernandez de las Heras L, Morales V, Navarro Llorens JM, Perera J (2011) Cholesterol degradation by Gordonia cholesterolivorans. Appl Environ Microbiol 77(14):4802–4810. doi:10.1128/AEM.05149-11
Duranti S, Milani CLugli GA, Turroni F, Mancabelli L, Sanchez B, Ferrario C, Viappiani A, Mangifesta M, Mancino W, Guiemonde M, Margolles A, van Sinderen D, Ventura M (2014a) Insights from genomes of representatives of the human gut commensal Bifidobacterium bifidum. Environ Microbiol (in press)
Duranti S, Turroni F, Lugli GA, Milani C, Viappiani A, Mangifesta M, Gioiosa L, Palanza P, van Sinderen D, Ventura M (2014b) Genomic characterization and transcriptional studies of the starchutilizing Bifidobacterium adolescentis 22L. Appl Environ Microbiol 80(19):6080–90
Edgar JR, Bell RM (1978) Biosynthesis in Escherichia coli fo sn-glycerol 3-phosphate, a precursor of phospholipid. J Biol Chem 253(18):6348–6353
Gerard P, Lepercq P, Leclerc M, Gavini F, Raibaud P, Juste C (2007) Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces. Appl Environ Microbiol 73(18):5742–5749. doi:10.1128/AEM. 02806-06
Ghiselli G, Schaefer EJ, Gascon P, Breser HB Jr (1981) Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science 214(4526):1239–1241
Gimpl G, Burger K, Fahrenholz F (1997) Cholesterol as modulator of receptor function. Biochemistry 36(36):10959–10974. doi:10.1021/bi963138w
Goff DC Jr, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, Psaty BM (2006) Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 113(5):647–656. doi:10.1161/CIRCULATIONAHA.105.552737
Grill JP, Cayuela C, Antoine JM, Schneider F (2000) Effects of Lactobacillus amylovorus and Bifidobacterium breve on cholesterol. Lett Appl Microbiol 31(2):154–156
Ishimwe N, Daliri EB, Lee BH, Fang F, Du G (2014) The perspective on cholesterol lowering mechanisms of probiotics. Mol Nutr Food Res. doi:10.1002/mnfr.201400548
Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR (2008) Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A 105(36):13580–13585. doi:10.1073/pnas.0804437105
Jones ML, Martoni CJ, Parent M, Prakash S (2012) Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr 107(10):1505–1513. doi:10.1017/S0007114511004703
Kimoto H, Ohmomo S, Okamoto T (2002) Cholesterol removal from media by lactococci. J Dairy Sci 85(12):3182–3188. doi:10.3168/jds.S0022-0302(02)74406-8
Kumar M, Nagpal R, Kumar R, Hemalatha R, Verma V, Kumar A, Chakraborty C, Singh B, Marotta F, Jain S, Yadav H (2012) Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res 2012:902917. doi:10.1155/2012/902917
Lahti L, Salonen A, Kekkonen RA, Salojarvi J, Jalanka-Tuovinen J, Palva A, Oresic M, de Vos WM (2013) Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. Peer J 1:e32. doi:10.7717/peerj.32
Liong MT, Shah NP (2006) Effects of a Lactobacillus casei synbiotic on serum lipoprotein, intestinal microflora, and organic acids in rats. J Dairy Sci 89(5):1390–1399. doi:10.3168/jds.S0022-0302(06)72207-X
Lye HS, Rusul G, Liong MT (2010) Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol. J Dairy Sci 93(4):1383–1392. doi:10.3168/jds. 2009-2574
McDonald D, Clemente JC, Kuczynski J, Rideout JR, Stombaugh J, Wendel D, Wilke A, Huse S, Hufnagle J, Meyer F, Knight R, Caporaso JG (2012) The Biological Observation Matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome. GigaScience 1(1):7. doi:10.1186/2047-217X-1-7
Meile L, Ludwig W, Rueger U, Gut C, Kaufmann P, Dasen G, Senger S, Teuber M (1997) Bifidobacterium lactis sp. nov., a moderately oxygen tolerant species isolated from fermented milk. Syst Appl Microbiol 20:57–64
Milani C, Duranti S, Lugli GA, Bottacini F, Strati F, Arioli S, Foroni E, Turroni F, van Sinderen D, Ventura M (2013) Comparative genomics of Bifidobacterium animalis subsp. lactis reveals a strict monophyletic bifidobacterial taxon. Appl Environ Microbiol 79(14):4304–4315
Milani C, Lugli GA, Duranti S, Turroni F, Bottacini F, Mangifesta M, Sanchez B, Viappiani A, Mancabelli L, Taminiau B, Delcenserie V, Barrangou R, Margolles A, van Sinderen D, Ventura M (2014) Genomic encyclopedia of type strains of the genus Bifidobacterium. Appl Environ Microbiol 80(20):6290–6302. doi:10.1128/AEM. 02308-14
Nagpal R, Kumar A, Kumar M, Behare PV, Jain S, Yadav H (2012) Probiotics, their health benefits and applications for developing healthier foods: a review. Fems Microbiol Lett 334(1):1–15. doi:10.1111/j.1574-6968.2012.02593.x
Noh DO, Kim SH, Gilliland SE (1997) Incorporation of cholesterol into the cellular membrane of Lactobacillus acidophilus ATCC 43121. J Dairy Sci 80(12):3107–3113. doi:10.3168/jds.S0022-0302(97)76281-7
Noriega L, Cuevas I, Margolles A, Los Reyes-Gavilan CGD (2006) Deconjugation and bile salts hydrolase activity by Bifidobacterium strains with acquired resistance to bile. Int Dairy J 16(8):850–855. doi:10.1016/j.idairyj.2005.09.008
Ooi LG, Liong MT (2010) Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 11(6):2499–2522. doi:10.3390/Ijms11062499
Parks DH, Beiko RG (2010) Identifying biologically relevant differences between metagenomic communities. Bioinformatics 26(6):715–721. doi:10.1093/bioinformatics/btq041
Parvez S, Kim HY, Lee HC, Kim DS (2006) Bile salt hydrolase and cholesterol removal effect by Bifidobacterium bifidum NRRL 1976. World J Microbiol Biotech 22(5):455–459. doi:10.1007/s11274-005-9056-6
Pereira DI, Gibson GR (2002a) Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol 68(9):4689–4693
Pereira DI, Gibson GR (2002b) Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 37(4):259–281. doi:10.1080/10409230290771519
Remagni MC, Paladino M, Locci F, Romeo FV, Zago M, Povolo M, Contarini G, Carminati D (2013) Cholesterol removal capability of lactic acid bacteria and related cell membrane fatty acid modifications. Folia Microbiol (Praha) 58(6):443–449. doi:10.1007/s12223-013-0228-8
Reuter G (1963) [Comparative Studies on the Bifidus Flora in the Feces of Infants and Adults. With a Contribution to Classification and Nomenclature of Bifidus Strains]. Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale 191:486–507
Reynier MO, Montet JC, Gerolami A, Marteau C, Crotte C, Montet AM, Mathieu S (1981) Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption of cholesterol. J Lipid Res 22(3):467–473
Rouillard JM, Zuker M, Gulari E (2003) OligoArray 2.0: design of oligonucleotide probes for DNA microarrays using a thermodynamic approach. Nucleic Acids Res 31(12):3057–3062
Ruiz L, Margolles A, Sanchez B (2013) Bile resistance mechanisms in Lactobacillus and Bifidobacterium. Front Microbiol 4:396. doi:10.3389/fmicb.2013.00396
Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, New York, USA
Sanchez B, Champomier-Verges MC, Stuer-Lauridsen B, Ruas-Madiedo P, Anglade P, Baraige F, de los Reyes-Gavilan CG, Johansen E, Zagorec M, Margolles A (2007) Adaptation and response of Bifidobacterium animalis subsp. lactis to bile: a proteomic and physiological approach. Appl Environ Microbiol 73(21):6757–6767. doi:10.1128/AEM.00637-07
Scardovi VFC (1974) Bifidobacterium catenulatum, Bifidobacterium dentium, and Bifidobacterium angulatum: three new species and their deoxyribonucleic and homology relationships. Int J Syst Bacteriol 24:6–20
Scardovi V, Trovatelli LD, Biavati B, Zani G (1979) Bifidobacterium cuniculi, Bifidobacterium choerinum, Bifidobacterium boum, and Bifidobacterium pseudocatenulatum: four new species and their deoxyribonucleic and homology relationships. Int J Syst Bacteriol 29:291–311
Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR et al (2008) The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci U S A 105:18964–9
Serafini F, Turroni F, Guglielmetti S, Gioiosa L, Foroni E, Sanghez V, Bartolomucci A, Motherway MO, Palanza P, van Sinderen D, Ventura M (2012) An efficient and reproducible method for transformation of genetically recalcitrant bifidobacteria. FEMS Microbiol Lett 333(2):146–152. doi:10.1111/j.1574-6968.2012.02605.x
Serafini F, Turroni F, Ruas-Madiedo P, Lugli GA, Milani C, Duranti S, Zamboni N, Bottacini F, van Sinderen D, Margolles A, Ventura M (2014) Kefir fermented milk and kefiran promote growth of Bifidobacterium bifidum PRL2010 and modulate its gene expression. Int J Food Microbiol 178:50–59. doi:10.1016/j.ijfoodmicro.2014.02.024
Tahri K, Grill JP, Schneider F (1997) Involvement of trihydroxyconjugated bile salts in cholesterol assimilation by bifidobacteria. Curr Microbiol 34(2):79–84
Tanaka H, Doesburg K, Iwasaki T, Mierau I (1999) Screening of lactic acid bacteria for bile salt hydrolase activity. J Dairy Sci 82(12):2530–2535. doi:10.3168/jds.S0022-0302(99)75506-2
Tissier H (1900) Recherchers sur la flora intestinale normale et pathologique du nourisson. University of Paris, Paris
Turroni F, Foroni E, Pizzetti P, Giubellini V, Ribbera A, Merusi P, Cagnasso P, Bizzarri B, De'angelis GL, Shanahan F, van Sinderen D, Ventura M (2009) Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl Environ Microbiol 75(6):1534–45
Turroni F, Bottacini F, Foroni E, Mulder I, Kim JH, Zomer A, Sanchez B, Bidossi A, Ferrarini A, Giubellini V, Delledonne M, Henrissat B, Coutinho P, Oggioni M, Fitzgerald GF, Mills D, Margolles A, Kelly D, van Sinderen D, Ventura M (2010a) Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci U S A 107(45):19514–19519. doi:10.1073/pnas.1011100107
Turroni F, Foroni E, O'Connell Motherway M, Bottacini F, Giubellini V, Zomer A, Ferrarini A, Delledonne M, Zhang Z, van Sinderen D, Ventura M (2010b) Characterization of the serpin-encoding gene of Bifidobacterium breve 210B. Appl Environ Microbiol 76(10):3206–3219. doi:10.1128/AEM.02938-09
Turroni F, Milani C, van Sinderen D, Ventura M (2011) Genetic strategies for mucin metabolism in Bifidobacterium bifidum PRL2010: an example of possible human-microbe co-evolution. Gut Microbe 2(3):183–189
Turroni F, Strati F, Foroni E, Serafini F, Duranti S, van Sinderen D, Ventura M (2012) Analysis of predicted carbohydrate transport systems encoded by Bifidobacterium bifidum PRL2010. Appl Environ Microbiol 78(14):5002–5012. doi:10.1128/AEM. 00629-12
Turroni F, Serafini F, Foroni E, Duranti S, O'Connell Motherway M, Taverniti V, Mangifesta M, Milani C, Viappiani A, Roversi T, Sanchez B, Santoni A, Gioiosa L, Ferrarini A, Delledonne M, Margolles A, Piazza L, Palanza P, Bolchi A, Guglielmetti S, van Sinderen D, Ventura M (2013) Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions. Proc Natl Acad Sci U S A 110(27):11151–11156. doi:10.1073/pnas.1303897110
Turroni F, Taverniti V, Ruas-Madiedo P, Duranti S, Guglielmetti S, Lugli GA, Gioiosa L, Palanza P, Margolles A, van Sinderen D, Ventura M (2014a) Bifidobacterium bifidum PRL2010 modulates the host innate immune response. Appl Environ Microbiol 80(2):730–740. doi:10.1128/AEM. 03313-13
Turroni F, Ventura M, Butto LF, Duranti S, O'Toole PW, Motherway MO, van Sinderen D (2014b) Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci 71(2):183–203. doi:10.1007/s00018-013-1318-0
Usman HA (2000) Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemic rats. J Dairy Sci 83(8):1705–1711. doi:10.3168/jds.S0022-0302(00)75039-9
Van der Geize R, Yam K, Heuser T, Wilbrink MH, Hara H, Anderton MC, Sim E, Dijkhuizen L, Davies JE, Mohn WW, Eltis LD (2007) A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages. Proc Natl Acad Sci U S A 104(6):1947–1952. doi:10.1073/pnas.0605728104
Ventura M, O'Flaherty S, Claesson MJ, Turroni F, Klaenhammer TR, van Sinderen D, O'Toole PW (2009) Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat Rev Microbiol 7(1):61–71. doi:10.1038/nrmicro2047
Yu NY, Wagner JR, Laird MR, Melli G, Rey S, Lo R, Dao P, Sahinalp SC, Ester M, Foster LJ, Brinkman FS (2010) PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26(13):1608–1615. doi:10.1093/bioinformatics/btq249
Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258(5081):468–471
Acknowledgments
We thank GenProbio srl for financial support of the Laboratory of Probiogenomics. This work was financially supported by a FEMS Jensen Award to FT. FT is a members of The Alimentary Pharmabiotic Centre, while DvS is also a member of the Alimentary Glycoscience Research Cluster, both funded by Science Foundation Ireland (SFI), through the Irish Government’s National Development Plan (Grant numbers SFI/12/RC/2273 and 08/SRC/B1393, respectively).
Conflict of interest
The authors declare no financial or commercial conflict of interest.
Compliance with the ethical standards
The authors declare that all the procedures used for murine experiments (housing and experiments) were conducted in accordance with the animal experimentation European Communities Council Directive of 24 November 1986 (86/EEC) and approved by the ethical commission of the University of Parma and by the Italian Institute of Health.
Author information
Authors and Affiliations
Corresponding author
Additional information
Ilaria Zanotti, Francesca Turroni, and Antonio Piemontese equally contributed to the work.
Rights and permissions
About this article
Cite this article
Zanotti, I., Turroni, F., Piemontese, A. et al. Evidence for cholesterol-lowering activity by Bifidobacterium bifidum PRL2010 through gut microbiota modulation. Appl Microbiol Biotechnol 99, 6813–6829 (2015). https://doi.org/10.1007/s00253-015-6564-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-015-6564-7